Dudediligence.

Sunshine Biopharma, Inc

SBFMNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$8.4MSep ’24$9.6MDec ’24$8.9MMar ’25$9.4MJun ’25$9.4MSep ’25$8.6MDec ’25$8.1MMar ’26$9.3MJun ’26
Net income, by quarter
−$1.2MSep ’24−$2.2MDec ’24−$1.2MMar ’25−$1.8MJun ’25−$883,820Sep ’25−$2.1MDec ’25−$1.2MMar ’26−$1.6MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$228,426$4.3M$24.1M$34.9M$36.3M
Gross profit$110,596$1.7M$8.3M$10.7M$12.3M
Operating income−$2.4M−$27.0M−$4.8M−$5.8M−$6.2M
Net income−$12.4M−$26.7M−$4.5M−$5.1M−$6.0M
Operating cash flow−$1.8M−$5.2M−$8.8M−$12.5M−$5.3M
Free cash flow−$1.8M−$5.4M−$8.9M−$14.2M−$5.5M
Cash$2.0M$21.8M$16.3M$9.7M$9.1M
Shares outstanding2.6M22.6M14.0K2.6M4.9M